| [1] | Ren Yan, Zheng SuJun. Experience in clinical treatment of drug-induced liver injury:a case report[J]. Journal of Clinical Hepatology, 2017, 33(12): 2395-2396. doi: 10.3969/j.issn.1001-5256.2017.12.029 |
| [2] | Liu ChengHai, Zhu ChunWu. Epidemic features, major causes, and diagnostic evaluation of herb-induced liver injury[J]. Journal of Clinical Hepatology, 2017, 33(5): 829-832. doi: 10.3969/j.issn.1001-5256.2017.05.007 |
| [3] | Hong YouZhi, Huang JiShui, Hong WenCong, Jiang TaoYuan. Clinical effect of entecavir combined with antituberculosis therapy in patients with tuberculosis complicated by chronic HBV infection[J]. Journal of Clinical Hepatology, 2016, 32(11): 2088-2091. doi: 10.3969/j.issn.1001-5256.2016.11.015 |
| [4] | Wang YueZhi, Zhang Yu. Research advances in drug- induced liver injury in the elderly[J]. Journal of Clinical Hepatology, 2016, 32(4): 821-824. doi: 10.3969/j.issn.1001-5256.2016.04.049 |
| [5] | Yang Jun, Yu YaLi, Zheng ZhangQing. Clinical features of drug- induced liver injury and primary biliary cirrhosis: a comparative analysis[J]. Journal of Clinical Hepatology, 2016, 32(4): 728-731. doi: 10.3969/j.issn.1001-5256.2016.04.024 |
| [6] | Shen ShuiYing, Wu Jun. Acute liver failure caused by antitubercular drugs: a report of one case[J]. Journal of Clinical Hepatology, 2015, 31(9): 1483-1484. doi: 10.3969/j.issn.1001-5256.2015.09.029 |
| [7] | Drug-induced Liver Disease Study Group, Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the management of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2015, 31(11): 1752-1769. doi: 10.3969/j.issn.1001-5256.2015.11.002 |
| [8] | Qi YaBin, Qiu Ling, Jiang HongLi, Zhang Rui, Hu YuLin. Clinical characteristics of drug-induced liver injury: an analysis of 394 cases[J]. Journal of Clinical Hepatology, 2014, 30(5): 438-441. doi: 10.3969/j.issn.1001-5256.2014.05.014 |
| [9] | Yu Zheng, Jia JiDong. Risk factors, diagnostic criteria, and drug discontinuation criteria for drug- induced liver injury[J]. Journal of Clinical Hepatology, 2013, 29(9): 674-677. doi: 10.3969/j.issn.1001-5256.2013.09.010 |
| [10] | Hu XingWu, Qi ChangJin, Zhou HongXing. Therapeutic efficacy of ursodeoxycholic acid for drug-induced liver disease[J]. Journal of Clinical Hepatology, 2012, 28(9): 695-696. |
| [11] | Su HaiBin, Wang HuiFen. Clinical significance of drug-induced liver failure[J]. Journal of Clinical Hepatology, 2012, 28(10): 738-739+747. |
| [12] | Dai WeiJia, Lai RongTao, Wang Hui, Xie Qing, Tang WeiLiang, Zhuang Yan, Gui HongLian, Yu MinJie, Xie JingDong, Zhou HuiJuan. The analysis of clinical features and risk factors in 113 patients with drug-induced liver injury[J]. Journal of Clinical Hepatology, 2011, 27(10): 1058-1061+1065. |
| [13] | Wang ChunYan, Li Bing. One case of congenital hepatic fibrosis and hepatitis B virus infection and drug-induced liver injury[J]. Journal of Clinical Hepatology, 2011, 27(12): 1318-1319. |
| [14] | Zhang YuLing, Li AiPing. Clinical observation of interferon combined with captopril in the treatment of chronic hepatitis B [J]. Journal of Clinical Hepatology, 2010, 26(2): 212-212. |
| [15] | Zhu ChaoHui, Li Nan, Wu Kai, Wang XueMing, Zhang Lin, Zhai JunShan, Wang YanMei. The effect of S-adenosyl-methionine treatment on drug-induced liver injury[J]. Journal of Clinical Hepatology, 2010, 26(6): 651-653. |
| [16] | Li ChunMing, Huang XiaoYun, Jin YueMing, Gong YuHua, Tan YouWen. Analysis of anti-fibrosis effect of combining lamivudine with captopril in 166 cases with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(2): 102-105. |
DownLoad: